FDA Inspection 1112213 — Changzhou Qianhong Biopharma Co., Ltd.
The FDA completed an inspection of Changzhou Qianhong Biopharma Co., Ltd. on October 23, 2019 in Changzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 23, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)